MedPath

DOPORIO 25 MG/250 MG COMPRIMIDOS EFG

DOPORIO 25 MG/250 MG COMPRIMIDOS EFG

Pending
Register Number

89624

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Jun 20, 2024

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89624
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

CARBIDOPA MONOHIDRATOActive
Quantity: 27 mg
Name: CARBIDOPA MONOHIDRATO
LEVODOPAActive
Quantity: 250 mg
Name: LEVODOPA

ATC CLASSIFICATION (3)

N04B
N04BA
N04BA02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.